Acronym BlueShell
Category
Aquaculture
Fisheries
Marine Biotechnology
Title Exploring Shellfish By products as sources of Blue Bioactivities
Programme International Cooperation
Instrument (FP6)
Contact Type (FP7)
Strand (Interreg)
NA
Theme (FP7)
Activity Area (FP6)
Regional Area (Interreg)
Action (COST)
NA
Specific Programme (FP7)
NA
Funding source National-European
Coordinator Katleen Raes
Coordinator email Katleen.Raes@UGent.be
Coordinator institution
UGent - Ghent University (Belgium)
Institutions involved
NA - Chalmers University of Technology (Sweden) ,
DIT - Dublin Institute of Technology (Ireland) ,
EV ILVO - Flanders Research Institute for Agriculture, Fisheries and Food (Belgium) ,
NA - Irish Fish Canners Ltd (Ireland) ,
CNR - National Research Council (Italy) ,
NOFIMA - Norwegian Institute of Food, Fisheries and Aquaculture Research (Norway) ,
Start year 2017
End year 2019
Funding (€) € 1,319,000
Website www.marinebiotech.eu/blueshell
Summary About 70% of annual shellfish production ends up as by - products. Apart from use in chitin/chitosan, this marine biomass is either used to make fertilizer/low value products or is sent to landfill, incinerated or dumped at sea. Blue Shell will address this problem by exploring 3 typica l shellfish by - products; shrimp shells , crab shells and defect mussels, for potential (bio)active compounds targeted at the sustainable supply of safe, healthy foods. Research indicates that the abundance of hepatopancreas tissue, the open circulatory system, the filtering nature and the shell structures render crustaceans and bivalves as sources of unique proteins/peptides, unusual fatty acids, pigments and chitin. Applying enzymatic hydrolysis o r fermentation will enhance bioactivity through controlled proteolysis, lipolysis and production of low molecular weight compounds. It will facilitate fractionation through lipid - protein disconnections and demineralization /de - proteinisation. Different star ter cultures will be tested against a standardized enzymatic hydrolysis as reference. Peptide - , lipid - and chitin - enriched fractions will be explored for (bio)activities relevant to: (i) functional foods development, (ii) food safety applications and ( iii) plant health applications. Molecular characterisation of the most active fractions will help identify the specific compounds involved. BlueShell will investigate upscaling feasibility and market potential for the most interesting cases
Keywords
Shellfish;
Bivalve;
Crustacean;
Mussel;
Bioactive compounds;
Shrimp;
Byproducts;
Crab;
Mollusc;
Human food;
Marine Region
76
Not associated to marine areas
0
Marine Region Map